About ECNM
About ECNM
About ECNM
The European Competence Network on Mastocytosis (ECNM) is a collaborative network established to improve the diagnosis, treatment and understanding of mastocytosis, a rare disease characterised by the accumulation of mast cells in various tissues.
The European Competence Network on Mastocytosis (ECNM) is a collaborative network established to improve the diagnosis, treatment and understanding of mastocytosis, a rare disease characterised by the accumulation of mast cells in various tissues.
The European Competence Network on Mastocytosis (ECNM) is a collaborative network established to improve the diagnosis, treatment and understanding of mastocytosis, a rare disease characterised by the accumulation of mast cells in various tissues.
Mission
The ECNM focuses on:
Mission
The ECNM focuses on:
Mission
The ECNM focuses on:
Enhancing access to accurate diagnostic tools and effective therapies
Enhancing access to accurate diagnostic tools and effective therapies
Enhancing access to accurate diagnostic tools and effective therapies
Developing and promoting diagnostic and treatment guidelines to ensure consistent and high-quality care for all patients
Developing and promoting diagnostic and treatment guidelines to ensure consistent and high-quality care for all patients
Developing and promoting diagnostic and treatment guidelines to ensure consistent and high-quality care for all patients
Building a robust network of Centres of Excellence and Reference Centres across Europe to support interdisciplinary cooperation
Building a robust network of Centres of Excellence and Reference Centres across Europe to support interdisciplinary cooperation
Building a robust network of Centres of Excellence and Reference Centres across Europe to support interdisciplinary cooperation
Investigating the causes, clinical progression and response to treatment of mastocytosis to drive innovation in care
Investigating the causes, clinical progression and response to treatment of mastocytosis to drive innovation in care
Investigating the causes, clinical progression and response to treatment of mastocytosis to drive innovation in care